I had the opportunity to chat with the leadership of Quantum Surgical.
Epione is a very interesting surgical robotic platform that has been developed by Quantum Surgical. It is a robotic-assisted technology that can plan, target, deliver and confirm tumor ablation.
The initial indication will be liver cancer which is one of the leading causes of cancer deaths worldwide. Since 1980, the incidence of liver cancer has more than tripled. Primary liver tumors were the third leading cause of tumor related death worldwide in 2020, with more than 900,000 new cases and 830,000 deaths globally.
The robot that offers 6 degrees of freedom and unprecedented dexterity to access difficult trajectories when targeting abdominal tumors and is designed to allow physicians their choice of any ablative technologies (radiofrequency, microwave, cryoablation, irreversible electroporation) so they can decide the right therapy for each individual patient.
Epione received CE mark approval in August 2021.
The robot and the team will be revealed at radiology conference, RSNA 2021 in Chicago this week. Looking forward to getting a closer look.
My full discussion with Quantum Surgical will be coming soon.